LEADER 01794nam 2200385Ia 450 001 996395082103316 005 20210104171344.0 035 $a(CKB)3810000000018300 035 $a(EEBO)2240891094 035 $a(OCoLC)ocn789659991e 035 $a(OCoLC)789659991 035 $a(EXLCZ)993810000000018300 100 $a20120426d1628 uy 0 101 0 $aeng 135 $aurbn||||a|bb| 200 10$aBy the King$b[electronic resource] $eA proclamation about the dissoluing of the Parliament. Whereas wee, for the generall good of our kingdome, caused our high Court of Parliament to assemble and meete .. 210 $aImprinted at London $cby Bonham Norton, and Iohn Bill, Printers to the Kings most Excellent Maiestie.$danno MDCXXVIII. [1626] 215 $a1 sheet ([1] p.) $ccoat of arms 300 $aTitle from caption and first lines of text. 300 $aRoyal coat of arms at head of title. 300 $aAt end of text: Giuen at our court at White-hall, this second day of March, in the fourth yeere of our reigne of Great Britaine, France, and Ireland. 300 $aLast indented line to right of init. begins: 'rous'. Cf. STC (2nd ed.). 300 $aReproduction of original in: National Library of Scotland--Crawford Collections. 330 $aeebo-0097 607 $aGreat Britain$xHistory$yCharles I, 1625-1649$vSources$vEarly works to 1800 607 $aGreat Britain$xPolitics and government$y1625-1649$vSources$vEarly works to 1800 608 $aProclamations$zEngland$y17th century.$2rbgenr 608 $aBroadsides$zEngland$y17th century.$2rbgenr 701 $aCharles$cKing of England,$f1600-1649.$0793295 801 0$bUMI 801 1$bUMI 906 $aBOOK 912 $a996395082103316 996 $aBy the King$92297757 997 $aUNISA LEADER 03936nam 2200565 450 001 9910789365603321 005 20230803034704.0 010 $a0-309-26705-6 010 $a0-309-26703-X 035 $a(CKB)3710000000103262 035 $a(EBL)3564289 035 $a(SSID)ssj0000957116 035 $a(PQKBManifestationID)12362208 035 $a(PQKBTitleCode)TC0000957116 035 $a(PQKBWorkID)10979903 035 $a(PQKB)11066308 035 $a(MiAaPQ)EBC3564289 035 $a(Au-PeEL)EBL3564289 035 $a(CaPaEBR)ebr10863770 035 $a(OCoLC)880439914 035 $a(EXLCZ)993710000000103262 100 $a20130724h20132013 uy| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt 182 $cc 183 $acr 200 04$aThe childhood immunization schedule and safety $estakeholder concerns, scientific evidence, and future studies /$fCommittee on the Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies 210 1$aWashington, District of Columbia :$cNational Academies Press,$d[2013] 210 4$dİ2013 215 $a1 online resource (235 p.) 300 $aDescription based upon print version of record. 311 $a0-309-26702-1 320 $aIncludes bibliographical references. 327 $aIntroduction -- Determination of the immunization schedule -- Existing data sources and systems -- Stakeholder concerns related to the safety of the immunization schedule -- Review of scientific findings -- Methodological approaches to studying health outcomes associated with the current immunization schedule: options, feasibility, ethical issues, and priorities -- Conclusions and recommendations. 330 $a"The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies reviews scientific findings and stakeholders concerns related to the safety of the recommended childhood immunization schedule. This report also identifies potential research approaches, methodologies and study designs that could inform this question, considering strengths, weaknesses as well as ethical and financial feasibility of each approach. This report draws on data from existing surveillance systems, such as the Vaccine Safety Datalink, could be used and offers the best means for ongoing research efforts regarding the safety of the schedule. In recognition of this, future federal research approaches should: collect and assess evidence regarding public confidence in and concerns about the entire childhood immunization schedule, with the goal to improve communication with health care professionals, and between health care professionals and the public regarding safety; standardize definitions of key elements of the schedule, and relevant health outcomes; establish research priorities on the basis of epidemiological evidence, biological plausibility, and feasibility; and continue to fund and support the Vaccine Safety Datalink project to study the safety of the recommended immunization schedule"--$cPublisher's description. 606 $aImmunization of children$xStandards$zUnited States 606 $aVaccination of children$xStandards$zUnited States 615 0$aImmunization of children$xStandards 615 0$aVaccination of children$xStandards 676 $a614.4/7083 712 02$aInstitute of Medicine (U.S.).$bCommittee on the Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule, 712 02$aInstitute of Medicine (U.S.).$bBoard on Population Health and Public Health Practice, 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910789365603321 996 $aThe childhood immunization schedule and safety$93788918 997 $aUNINA